Autoantibodies Neutralizing Type I INFs May Be Associated with Efficacy of Tocilizumab in COVID-19 Pneumonia

Detalles Bibliográficos
Autores principales: Chauvineau-Grenier, Angélique, Bastard, Paul, Casanova, Jean-Laurent, Rossi, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177133/
https://www.ncbi.nlm.nih.gov/pubmed/35676568
http://dx.doi.org/10.1007/s10875-022-01295-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177133/
https://www.ncbi.nlm.nih.gov/pubmed/35676568
http://dx.doi.org/10.1007/s10875-022-01295-5

Ejemplares similares